Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GZPHF)
2.34
0.00 (0.00%)
USD |
OTCM |
Sep 03, 16:00
Guangzhou Baiyunshan Pharmaceutical Holdings Net Income (Quarterly) : 49.21M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.21M |
| March 31, 2026 | 263.39M |
| December 31, 2025 | -47.59M |
| September 30, 2025 | 114.87M |
| June 30, 2025 | 99.33M |
| March 31, 2025 | 255.26M |
| December 31, 2024 | -40.16M |
| September 30, 2024 | 86.70M |
| June 30, 2024 | 87.86M |
| March 31, 2024 | 282.65M |
| December 31, 2023 | 45.74M |
| September 30, 2023 | 138.95M |
| June 30, 2023 | 135.71M |
| March 31, 2023 | 287.79M |
| December 31, 2022 | 79.91M |
| September 30, 2022 | 136.55M |
| June 30, 2022 | 129.65M |
| March 31, 2022 | 297.94M |
| December 31, 2021 | 71.92M |
| September 30, 2021 | 132.89M |
| June 30, 2021 | 146.42M |
| March 31, 2021 | 263.00M |
| December 31, 2020 | 38.93M |
| September 30, 2020 | 137.11M |
| June 30, 2020 | 88.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 180.34M |
| December 31, 2019 | 8.682M |
| September 30, 2019 | 100.10M |
| June 30, 2019 | 177.69M |
| March 31, 2019 | 217.20M |
| December 31, 2018 | 3.528M |
| September 30, 2018 | 124.89M |
| June 30, 2018 | 271.68M |
| March 31, 2018 | 145.70M |
| December 31, 2017 | 89.14M |
| September 30, 2017 | 50.69M |
| June 30, 2017 | 100.20M |
| March 31, 2017 | 73.09M |
| December 31, 2016 | 67.55M |
| September 30, 2016 | 35.12M |
| June 30, 2016 | 67.25M |
| March 31, 2016 | 64.77M |
| December 31, 2015 | 56.57M |
| September 30, 2015 | 30.35M |
| June 30, 2015 | 67.48M |
| March 31, 2015 | 59.93M |
| December 31, 2014 | 54.82M |
| September 30, 2014 | 28.55M |
| June 30, 2014 | 58.70M |
| March 31, 2014 | 54.39M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sinopharm Group Co., Ltd. | -- |
| PomDoctor Ltd. | -- |
| Cencora, Inc. | 776.67M |
| Cardinal Health, Inc. | 400.00M |
| McKesson Corp. | 1.032B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.764B |
| Total Expenses (Quarterly) | 2.718B |
| EPS Diluted (Quarterly) | 0.0282 |
| Enterprise Value | 3.923B |
| Gross Profit Margin (Quarterly) | 12.63% |
| Profit Margin (Quarterly) | 1.78% |
| Earnings Yield | 9.68% |
| Operating Earnings Yield | 10.78% |
| Normalized Earnings Yield | 9.756 |